HV Insights

Agenda Overview

Friday, February 28th 
6:30 pm - 8:30 pm     Welcome Reception

Saturday, February 29th 
7:00 am - 7:30 am      Breakfast
7:30 am - 12:30 pm    General Session

Four Seasons Las Vegas
3960 South Las Vegas Blvd
Las Vegas, NV 89119


TAVR vs. SAVR and VIV in Young Patients: Valve Survival, Patient Survival & Eventual Need for Anticoagulation
Maurice Sarano, MD 

A Potential Game Changer in the Choice of AVR (New PROACT Xa Clinical Study)
Tracy Y. Wang, MD, MHS, MSc, FACC, FAHA | Duke University 

SAVR, TAVR, ViV – Life in the Fast Lane: Who, What, When
Marc Gerdisch, MD, FACS, FACC, FHRS | St. Francis Health

Blood Thinning in 2019 and Beyond: Impact on AVR Patients and Artificial Prosthesis Selection
Mohanakrishnan Sathyamoorthy, MD, FACC | TCU & UNTHSC School of Medicine